Technical Analysis for FBRX - Forte Biosciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 0.75 | 5.50% | 0.04 |
FBRX closed up 5.5 percent on Wednesday, May 8, 2024, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
180 Bullish Setup | Bullish Swing Setup | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
20 DMA Resistance | Bearish | 5.50% | |
BB Squeeze Ended | Range Expansion | 5.50% | |
20 DMA Resistance | Bearish | 4.17% | |
Bollinger Band Squeeze | Range Contraction | 4.17% | |
BB Squeeze + Upper Band Touch | Range Contraction | 4.17% |
Alert | Time |
---|---|
Possible NR7 | about 17 hours ago |
60 Minute Opening Range Breakout | about 19 hours ago |
Up 5% | about 19 hours ago |
Up 3% | about 19 hours ago |
Gap Up Partially Closed | about 21 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Forte Biosciences, Inc. is a clinical stage, dermatology company developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric (3 years of age and older) patients with atopic dermatitis. There is a significant unmet need for safe and effective therapies particularly for pediatric atopic dermatitis patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Monoclonal Antibodies Dermatology Atopic Dermatitis Dermatitis Skin Diseases Type I Hypersensitivity Atopy Sodium Hypochlorite Washes
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Monoclonal Antibodies Dermatology Atopic Dermatitis Dermatitis Skin Diseases Type I Hypersensitivity Atopy Sodium Hypochlorite Washes
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.1 |
52 Week Low | 0.38 |
Average Volume | 26,792 |
200-Day Moving Average | 0.69 |
50-Day Moving Average | 0.71 |
20-Day Moving Average | 0.72 |
10-Day Moving Average | 0.72 |
Average True Range | 0.05 |
RSI (14) | 56.14 |
ADX | 12.09 |
+DI | 13.26 |
-DI | 15.30 |
Chandelier Exit (Long, 3 ATRs) | 0.63 |
Chandelier Exit (Short, 3 ATRs) | 0.78 |
Upper Bollinger Bands | 0.77 |
Lower Bollinger Band | 0.68 |
Percent B (%b) | 0.79 |
BandWidth | 12.03 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0006 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.78 | ||||
Resistance 3 (R3) | 0.78 | 0.76 | 0.78 | ||
Resistance 2 (R2) | 0.76 | 0.76 | 0.77 | 0.77 | |
Resistance 1 (R1) | 0.76 | 0.75 | 0.76 | 0.76 | 0.77 |
Pivot Point | 0.74 | 0.74 | 0.75 | 0.75 | 0.74 |
Support 1 (S1) | 0.74 | 0.74 | 0.74 | 0.74 | 0.73 |
Support 2 (S2) | 0.72 | 0.73 | 0.73 | 0.73 | |
Support 3 (S3) | 0.72 | 0.72 | 0.73 | ||
Support 4 (S4) | 0.72 |